Table of Contents
Company Snapshot
CRISPR Therapeutics: Company Overview
CRISPR Therapeutics: Overview and Key Facts
CRISPR Therapeutics: Overview
CRISPR Therapeutics: Key Facts
CRISPR Therapeutics: Key Employees
CRISPR Therapeutics: Key Employee Biographies
CRISPR Therapeutics: Major Products and Services
CRISPR Therapeutics: Company History
CRISPR Therapeutics: Management Statement
CRISPR Therapeutics: Key Competitors
CRISPR Therapeutics: Company Analysis
CRISPR Therapeutics: Business Description
CRISPR Therapeutics: SWOT Analysis
CRISPR Therapeutics: SWOT Overview
CRISPR Therapeutics: Strengths
CRISPR Therapeutics: Weaknesses
CRISPR Therapeutics: Opportunities
CRISPR Therapeutics: Threats
CRISPR Therapeutics: Corporate Financial Deals Activity
CRISPR Therapeutics: Financial Deals Overview
CRISPR Therapeutics: Targets and Partners
CRISPR Therapeutics: Top Deals 2013 – 2017YTD*
CRISPR Therapeutics: Advisors
CRISPR Therapeutics: Top Legal Advisors
CRISPR Therapeutics: Top Financial Advisors
CRISPR Therapeutics: Capital Raising
CRISPR Therapeutics: Partnership
CRISPR Therapeutics: Private Equity and Ownership
CRISPR Therapeutics: Recent Developments
CRISPR Therapeutics: News and Events Summary
CRISPR Therapeutics: Business Expansion
CRISPR Therapeutics: Corporate Governance
CRISPR Therapeutics: Financial Deals
CRISPR Therapeutics: Financial Performance
CRISPR Therapeutics: Grants
CRISPR Therapeutics: Market Developments
CRISPR Therapeutics: Regulatory and Legal Events
CRISPR Therapeutics: Research & Development
CRISPR Therapeutics: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine
Table 1: CRISPR Therapeutics: Key Facts
Table 2: CRISPR Therapeutics: Key Employees
Table 3: CRISPR Therapeutics: Key Competitors
Table 4: CRISPR Therapeutics: Deal Activity by Deal Type - Volume (TTM*)
Table 5: CRISPR Therapeutics: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 6: CRISPR Therapeutics: Targets and Partners
Table 7: CRISPR Therapeutics: Top Deals 2013 - 2017YTD*
Table 8: CRISPR Therapeutics: Legal Advisor Ranking by Value (US$m)
Table 9: CRISPR Therapeutics: Financial Advisor Ranking by Value (US$m)
Table 10: CRISPR Therapeutics: Capital Raising Volume and Value Trend (2013 - YTD*2017)
Table 11: CRISPR Therapeutics: Capital Raising by Deal Type (2013 - YTD*2017)
Table 12: CRISPR Therapeutics: Partnership Volume and Value Trend (2013 - YTD*2017)
Table 13: CRISPR Therapeutics: Partnership Trend by Deal Type (2013 - YTD*2017)
Table 14: CRISPR Therapeutics: Private Equity and Ownership Volume and Value Trend (2013 - YTD*2017)
Table 15: CRISPR Therapeutics: Private Equity and Ownership Volume by Deal Type (2013 - YTD*2017)
Table 16: CRISPR Therapeutics: News and Events Summary
Table 17: CRISPR Therapeutics: Business Expansion
Table 18: CRISPR Therapeutics: Corporate Governance
Table 19: CRISPR Therapeutics: Financial Deals
Table 20: CRISPR Therapeutics: Financial Performance
Table 21: CRISPR Therapeutics: Grants
Table 22: CRISPR Therapeutics: Market Developments
Table 23: CRISPR Therapeutics: Regulatory and Legal Events
Table 24: CRISPR Therapeutics: Research & Development
Table 25: CRISPR Therapeutics: Strategy and Operations
【免責事項】
http://www.globalresearch.jp/disclaimer